March 03, 2015 1:50 PM ET


Company Overview of Anadys Pharmaceuticals Inc.

Key Executives for Anadys Pharmaceuticals Inc.

NameBoard RelationshipsTitleAge
Stephen T. Worland Ph.D.23 RelationshipsChief Executive Officer and Member of Strategic Committee56
Peter T. Slover CPANo RelationshipsPrincipal Financial Officer, Principal Accounting Officer and Vice President of Finance & Operations39
James Appleman Ph.D.13 RelationshipsChief Scientific Officer and Senior Vice President of Research57
Devron R. Averett Ph.D.9 RelationshipsChief Scientific Counsel and Member of Clinical & Scientific Advisory Board64
James L. Freddo M.D.16 RelationshipsChief Medical Officer and Senior Vice President of Drug Development59

Anadys Pharmaceuticals Inc. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Devron R. Averett Ph.D. 9 RelationshipsAnadys Pharmaceuticals Inc.64
Douglas D. Richman M.D. 129 RelationshipsChimerix, Inc.--
Jason S. Fisherman M.D., MBA 62 RelationshipsSynthesis Capital57
K. C. Nicolaou Ph.D. 41 RelationshipsArray BioPharma, Inc.--
John G. McHutchison M.D., FRACP 30 RelationshipsGilead Sciences Inc.--
View All Board Members

Anadys Pharmaceuticals Inc. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Advisory Board M.D.Douglas D. Richman129 Relationships8 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$120.0K
Total Value of Options$425.0K
Compensation as of Fiscal Year 2010
Anadys Pharmaceuticals Inc. CEO Compensation
Industry Average


Eveready Industries India Limited Announces P H Ravikumar Ceased to Be Independent Director
March 02, 2015 9:29 AM ET
SCA Announces Executive Changes
March 02, 2015 7:07 AM ET
SCA Appoints Linda Nyberg as Vice President of Media Relations and Online Communications
February 26, 2015 12:00 AM ET
Hipolin Limited Announces Management Appointments
February 23, 2015 10:19 AM ET
Harbinger Group Inc. Appoints Curtis Glovier as Class II Director
February 20, 2015 10:05 PM ET

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Anadys Pharmaceuticals Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at